Skip to main content
Premium Trial:

Request an Annual Quote

Possible Dx for CAD Highlighted at American Heart Association Conference

Premium

A small study has uncovered 17 proteins that may eventually become the basis of a urine-based test to distinguish people with coronary artery disease from those who don't.

The preliminary findings were described in a study published in January in the Journal of Proteome Research and presented at a poster at last week's American Heart Association's Arteriosclerosis, Thrombosis, and Vascular Biology Annual conference in Washington.

The team of researchers first set out to differentiate proteins associated with coronary artery disease in blood and urine. While "significant discriminatory power" was achieved in urine, it was not for blood, they said in the JPR study. Based on that, they performed a urine proteomic analysis and identified 17 collagen fragments, known to be present on the surface of atherosclerotic plaques.

The set of proteins had a sensitivity of 81 percent, specificity of 92 percent, and accuracy of 84 percent.

Larger studies are needed to confirm the findings of the study, but "our data suggests that proteome analysis shows great promise," Constantin von zur Muehlen, the lead author on the study and a cardiology professor at the University Hospital Freiburg's cardiology department in Germany, said in a statement last week.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.